Stefanie JeffreyProfessor Stanford University School of Medicine
Nicholas DracopoliVice President Janssen R&D
Edith Szafer GlusmanSenior Research Associate Genentech
Dario Marchetti Professor, Director, CTC Core Facility Baylor College of Medicine
The 5th Annual World CTC Summit enables oncology drug developers and biomarker researchers to discover cutting edge data, industry-defining strategies and expand their network to gain exclusive insight into the future of circulating biomarker research.
Through an interactive and solution-led conference agenda, attendees will fully understand how to best harness circulating biomarkers as powerful diagnostic tools to overcome tumour heterogeneity and drive forward real time clinical development of targeted cancer therapies.
Why Attend World CTC?
Success within the circulating biomarker industry centers around effective collaboration and trusting partnerships between drug developers and specialist technology providers. As such, gone are the days of repetitive powerpoint presentations as the World CTC Summit agenda promotes interaction and audience engagement via:
“The World CTC Summit attracts important members across the CTC study community including diagnosticians, drug developers, technology providers and clinicians.” Silicon Biosystems
"I found this CTC meeting very interesting and made clever, fruitful connections with scientists, clinicians and big pharma companies. Many connections could be made thanks to the speed networking with the exchange of business cards! This meeting was a real success!” Université Montpellier
“I really enjoyed the wealth of knowledge on CTCs. The networking session was of great benefit. As a person new to CTCs, it was wonderful networking with the other attendees.” Genentech
“Excellent!! Great way to learn about the status quo of CTCs (I was a CTC novice 2 months ago).”